Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the...

Related Keywords

,Kezar Life Sciences ,Instagram ,Compensation Committee ,Nasdaq ,Twitter ,Facebook ,Kezar Life Sciences Inc ,Linkedin ,Nasdaq Listing Rule ,Life Sciences ,Markets ,